Table 1. Baseline study participant data.
Values are given as mean of baseline pre-treatment periods over the 2-study days ± SD (range). BMI: body mass index; bpm: beats per minute; CI: cardiac index; DBP: diastolic BP; SBP: PWV: pulse wave velocity; systolic BP; SVRI: systemic vascular resistance index.
| Parameter | n = 10 |
|---|---|
| Age, years | 31 ± 10 (20 – 49) |
| Sex (M/F) | 8/2 |
| BMI, kg/m2 | 23.7 ± 1.9 (20.4 – 27.0) |
| SBP, mmHg | 123 ± 9 (112 – 134) |
| DBP, mmHg | 63 ± 9 (49 – 72) |
| Pulse, bpm | 63 ± 8 (48 – 72) |
| SVRI, dyne/s/m2/cm5 | 1796 ± 355 (1420 – 2400) |
| CI, l/min1/m2 | 4.4 ± 0.8 (3.5 – 5.3) |
| PWV, m/s | 5.4 ± 0.9 (4.1 – 6.5) |
| Serum creatinine, mg/dl | 0.92 ± 0.11 (0.77 – 1.09) |
| 24h urine sodium, mmol/d | 89 ± 15 (56 – 105) |
| Plasma ET-1, pg/ml | 1.2 ± 0.4 (0.3 – 1.6) |
| Urine ET-1 excretion, pg/min | 0.87 ± 0.42 (0.27 – 1.42) |